Can zapping the brain while in virtual reality quiet anxious overthinking?

NCT ID NCT03915041

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are testing whether combining a mild brain stimulation technique called tDCS with virtual reality can reduce anxious rumination in healthy people who tend to ruminate. The study enrolls 20 adults who score high on a rumination scale but do not have a psychiatric or anxiety disorder. Participants receive either active or sham brain stimulation while watching a virtual reality scene, and researchers measure changes in rumination using a questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS) combined with virtual reality
What this could lead to
If it works, this could point toward a non-drug way to help people who get stuck in repetitive, anxious thinking.
What could go wrong
This is a very small, early study of 20 healthy volunteers, so any effect may be modest or may not hold up in larger groups or in people with anxiety disorders. tDCS is generally considered safe but can cause mild scalp tingling or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

May 2019

Finished

Aug 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Without any particular ethnic and psychosocial criteria * Subject to ruminations (personality trait) documented by a RRS-SF score \>30 * Subjects with score to BDI scal \<14 assessed during first visit * Subjects without psychiatric or addictive disorders. * Subjects who do not meet all the diagnostic criteria for an anxiety disorder or characterized depressive episode. Exclusion Criteria: * contraindication to tDCS (neurosurgical history, intracranial device, skin problems) * current virtual reality intolerance * history of psychiatric or addictive disorders * Use of psychotropic drugs * Use of non psychotropic treatments significantly influencing mood or level of anxiety * pregnant or breast-feeding women * Neurological pathology, locomotor disability, or sensory (vestibular, visual, auditory ...)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rumination are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rumination disorder Rumination Syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital

    Nantes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.